Gupta, Shiv K. et al
"Discordant In Vitro and In Vivo Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts." Clinical Cancer Research
20.14
(2014):
3730-3741.
Web. 21 April. 2021.